Companies /Financial Services

aTyr Pharma Inc

NASDAQ: LIFE Insurance Brokers
$39.60
▲ $0.49 (+1.25%) today
Markets open · 4:06pm ET
Today · % change

Fundamentals

Market Cap
$3.7B
Profit Margin
-18.1%
Revenue (TTM)
$586.5M
EPS (TTM)
$-1.69
52-Week Range
$9 – $41
Street Target
$34.88

About LIFE

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

LIFE Coverage

11:05am ET
Health and Healthcare

Wednesday’s Top Biopharma Winners

Trump said last week that companies in the health care sector are “getting away with murder,” and that something had to change. The sector has pulled back slightly since then, but there…

Chris Lange
10:45am ET
Health and Healthcare

aTyr Pharma Drops on Clinical Update

aTyr Pharma shares dropped early on Tuesday after the company announced clinical results from its exploratory trials assessing the safety and potential activity of Resolaris.

Chris Lange
10:15am ET
Health and Healthcare

aTyr Receives FDA Fast Track Designation

aTyr Pharma watched its shares climb early on Monday after the company announced that its product candidate Resolaris was granted Fast Track designation by the FDA.

Chris Lange
4:04pm ET
Investing

The 52-Week Low Club for Friday

April 8, 2016: Here are four stocks trading with relatively heavy volume among 22 equities making new 52-week lows in Friday’s session. The day’s NYSE winners led losers by about 3-to-1. The…

Paul Ausick
9:15am ET
Health and Healthcare

Thermo Fisher to Acquire Life Technologies

ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share).…

Paul Ausick